NLS Pharmaceutics Statistics Share Statistics NLS Pharmaceutics has 3.16M
shares outstanding. The number of shares has increased by 27.81%
in one year.
Shares Outstanding 3.16M Shares Change (YoY) 27.81% Shares Change (QoQ) -12.16% Owned by Institutions (%) 22.34% Shares Floating 1.99M Failed to Deliver (FTD) Shares 789 FTD / Avg. Volume 0.19%
Short Selling Information The latest short interest is 105.97K, so 2.16% of the outstanding
shares have been sold short.
Short Interest 105.97K Short % of Shares Out 2.16% Short % of Float 2.36% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.8 and the forward
PE ratio is 0.05.
NLS Pharmaceutics's PEG ratio is
0.
PE Ratio -0.8 Forward PE 0.05 PS Ratio 0 Forward PS 0.1 PB Ratio 1.13 P/FCF Ratio -0.37 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for NLS Pharmaceutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.69,
with a Debt / Equity ratio of 0.
Current Ratio 2.69 Quick Ratio 2.69 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -29.2
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-330.13K Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -56.56% in the
last 52 weeks. The beta is 0.15, so NLS Pharmaceutics's
price volatility has been higher than the market average.
Beta 0.15 52-Week Price Change -56.56% 50-Day Moving Average 2.16 200-Day Moving Average 1.99 Relative Strength Index (RSI) 49.59 Average Volume (20 Days) 418,993
Income Statement
Revenue n/a Gross Profit -3.32K Operating Income -4.38M Net Income -1.98M EBITDA -3.63M EBIT -3.64M Earnings Per Share (EPS) -2.63
Full Income Statement Balance Sheet The company has 1.67M in cash and 0 in
debt, giving a net cash position of 1.67M.
Cash & Cash Equivalents 1.67M Total Debt n/a Net Cash n/a Retained Earnings -74.43M Total Assets 1.19M Working Capital -6.53M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.27M
and capital expenditures -3.92K, giving a free cash flow of -4.27M.
Operating Cash Flow -4.27M Capital Expenditures -3.92K Free Cash Flow -4.27M FCF Per Share -5.67
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields NLSP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for NLSP.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 27, 2024. It was a
backward
split with a ratio of 1:40.
Last Split Date Sep 27, 2024 Split Type backward Split Ratio 1:40
Scores Altman Z-Score -148.37 Piotroski F-Score 1
